Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Surgical treatment for patients with idiopathic pulmonary fibrosis and lung cancer: postoperative acute exacerbation of idiopathic pulmonary fibrosis and outcomes
Authors
Keywords
-
Journal
SURGERY TODAY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-04
DOI
10.1007/s00595-021-02343-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thrombomodulin alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Randomized, Double-blind, Placebo-controlled Trial
- (2020) Yasuhiro Kondoh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Perioperative pirfenidone treatment as prophylaxis against acute exacerbation of idiopathic pulmonary fibrosis: a single-center analysis
- (2020) Keigo Sekihara et al. SURGERY TODAY
- Effect of nintedanib on non‐small cell lung cancer in a patient with idiopathic pulmonary fibrosis: A case report and literature review
- (2020) Toshihiro Shiratori et al. Thoracic Cancer
- Effectiveness of pirfenidone for idiopathic pulmonary fibrosis associated with pleuroparenchymal fibroelastosis–like lesions and nonspecific interstitial pneumonia
- (2020) Susumu Sakamoto et al. Clinical Respiratory Journal
- Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
- (2019) Beatriz Ballester et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Common Pathogenetic Mechanisms Between IPF and Lung Cancer
- (2019) A. Tzouvelekis et al. CHEST
- Therapeutic Role of Recombinant Human Soluble Thrombomodulin for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2019) Takuma Isshiki et al. Medicina-Lithuania
- Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: a retrospective cohort study
- (2019) Hongseok Yoo et al. BMC Pulmonary Medicine
- Perioperative pirfenidone treatment for lung cancer patients with idiopathic pulmonary fibrosis
- (2019) Masatoshi Kanayama et al. SURGERY TODAY
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Survival after repeated surgery for lung cancer with idiopathic pulmonary fibrosis: a retrospective study
- (2018) Seijiro Sato et al. BMC Pulmonary Medicine
- The Role of TGF-β Signaling in Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
- (2018) Akira Saito et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New risk scoring system for predicting acute exacerbation of interstitial pneumonia after chemotherapy for lung cancer associated with interstitial pneumonia
- (2018) Kazutoshi Isobe et al. LUNG CANCER
- The Activities of Daily Living after an Acute Exacerbation of Idiopathic Pulmonary Fibrosis
- (2017) Kazuya Koyama et al. INTERNAL MEDICINE
- Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study
- (2017) Kenta Furuya et al. RESPIRATORY MEDICINE
- Idiopathic pulmonary fibrosis
- (2017) Fernando J. Martinez et al. Nature Reviews Disease Primers
- Effect of Perioperative Pirfenidone Treatment in Lung Cancer Patients With Idiopathic Pulmonary Fibrosis
- (2016) Takekazu Iwata et al. ANNALS OF THORACIC SURGERY
- Nintedanib in NSCLC: evidence to date and place in therapy
- (2016) Giuseppe Bronte et al. Therapeutic Advances in Medical Oncology
- Long-term results and predictors of survival after surgical resection of patients with lung cancer and interstitial lung diseases
- (2015) Toshihiko Sato et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Recombinant Human Soluble Thrombomodulin Treatment for Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Study
- (2015) Takuma Isshiki et al. RESPIRATION
- Effectiveness of combined therapy with pirfenidone and inhaled N-acetylcysteine for advanced idiopathic pulmonary fibrosis: A case-control study
- (2015) Susumu Sakamoto et al. RESPIROLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Experience with perioperative pirfenidone for lung cancer surgery in patients with idiopathic pulmonary fibrosis
- (2014) Takekazu Iwata et al. SURGERY TODAY
- Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer
- (2013) Toshihiko Sato et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: The potential risk of extensive radiation pneumonitis
- (2013) Shinsaku Yamaguchi et al. LUNG CANCER
- The importance of intraoperative fluid balance for the prevention of postoperative acute exacerbation of idiopathic pulmonary fibrosis after pulmonary resection for primary lung cancer
- (2012) Y. Mizuno et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- A Case of Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Proton Beam Therapy for Non-small Cell Lung Cancer
- (2012) T. Nagano et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis
- (2012) Fiorella Calabrese et al. PATHOLOGY
- Efficacy of Chemotherapy for Advanced Non-Small Cell Lung Cancer with Idiopathic Pulmonary Fibrosis
- (2012) Naohiro Watanabe et al. RESPIRATION
- Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia
- (2012) TAKASHI KINOSHITA et al. Oncology Letters
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis of Microscopic Usual Interstitial Pneumonia Pattern after Lung Cancer Surgery
- (2011) Taichiro Goto et al. Annals of Thoracic and Cardiovascular Surgery
- Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis
- (2011) Yuichi Saito et al. ANNALS OF THORACIC SURGERY
- Acute Exacerbation of Idiopathic Interstitial Pneumonia Following Lung Surgery in 3 of 68 Consecutive Patients: A Retrospective Study
- (2011) Susumu Sakamoto et al. INTERNAL MEDICINE
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Safety of Postoperative Administration of Human Urinary Trypsin Inhibitor in Lung Cancer Patients with Idiopathic Pulmonary Fibrosis
- (2011) Yoshikane Yamauchi et al. PLoS One
- Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography
- (2011) Hidemi Suzuki et al. SURGERY TODAY
- Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung disease
- (2011) AKIRA IYODA et al. Experimental and Therapeutic Medicine
- Clinical characteristics of acute respiratory deterioration in pulmonary fibrosis associated with lung cancer following anti-cancer therapy
- (2009) Kazutoshi ISOBE et al. RESPIROLOGY
- Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis?
- (2008) Atsushi Watanabe et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More